CBio A/S
Core data
Name | CBio A/S |
Address | Transformervej 8, 2860, Søborg |
Founded | Jan 21, 2019 |
| 8 / 8 | |
Locations (P-units) | 1View locations |
Website | https://www.cbio.dk/ |
 LinkedIn | cbio-a-s |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Name | CBio A/S |
Address | Transformervej 8, 2860, Søborg |
Founded | Jan 21, 2019 |
| 8 / 8 |
Locations (P-units) | 1View locations |
Website | https://www.cbio.dk/ |
| LinkedIn | cbio-a-s |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Keep track of CBio A/S
Description
Cbio is a biopharmaceutical company developing T-cell-based immunotherapies for cancer, with research, development, and manufacturing activities in Søborg, Copenhagen.
Cbio develops next-generation T-cell therapies for solid tumors and manufactures cell-based Advanced Therapy Medicinal Products for clinical use. Its first product, novoleucel, is a broad-spectrum T-cell therapy designed to target and eradicate tumor cells.
Company's own description on virk.dk
The company's purpose is to conduct research, development and manufacturing of cell-based therapies for its partners and for own-sponsored programs for the benefit of cancer and other seriously ill patients.
Products & services
REVITA technology platform · novoleucel · T-cell therapies · TIL therapy products · Fast Lymphocyte Expansion (FLeX) protocol · Manufacturing of cell-based Advanced Therapy Medicinal Products
Industries
Biopharmaceuticals · T-cell therapy · Cancer immunotherapy · Cell-based Advanced Therapy Medicinal Products
Customer types
Cancer patients · Late-stage cancer patients · Clinical users
Financials
| Reporting period | 2025DKK | ||||||
|---|---|---|---|---|---|---|---|
| Gross profit | 3,671,653 | ||||||
| Profit before tax | -2,265,801 | ||||||
| Net income | -1,802,853 | ||||||
| Total assets | 42,193,453 | ||||||
| Equity | 10,475,706 | ||||||
| Avg. employees | 7 | ||||||
2019–2025 Unlock financial history | |||||||
Datapublica Risk Score
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Gazelle
Loading gazelle status…
Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.
Founders
| Founder | Registered as founder | Current roles | Ownership |
|---|---|---|---|
| Ulrik Cordes | Registered as founderJan 21, 2019 | Current roles BoardManagement | Ownership 33.33–49.99 %Indirect via CBio Holding ApS |
People
| Person | Roles | Titles |
|---|---|---|
| Christian Henri Leroy | Roles Board | TitlesBESTYRELSESMEDLEM |
| Else Beth Trautner | Roles Board | TitlesFORMAND |
| Karin Cecilia Hultén | Roles Board | TitlesBESTYRELSESMEDLEM |
| Lars Rabe Tønnesen | Roles Board | TitlesBESTYRELSESMEDLEM |
| Ulrik Cordes | Roles BoardManagement | TitlesBESTYRELSESMEDLEM • DIREKTØR |
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| Beierholm | AuditorAnders Ladegaard | RoleState Authorised Public Accountant | FromJul 1, 2026 |
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
| Ownership33.33–49.99 % | Voting rights33.33 % | FromFeb 29, 2024 | |
| Ownership10–14.99 % | Voting rights10 % | FromSep 10, 2021 | |
| Ownership10–14.99 % | Voting rights10 % | FromSep 26, 2019 | |
| Ownership5–9.99 % | Voting rights5 % | FromSep 10, 2021 | |
Unknown Other Participant | Ownership5–9.99 % | Voting rights5 % | FromSep 10, 2021 |
| Ownership5–9.99 % | Voting rights5 % | FromFeb 29, 2024 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| Ulrik Cordes | Ownership through | 33.33–49.99 % |
| Karin Cecilia Hultén | Ownership through | 10–14.99 % |
| 🇱🇺SeedALFA Holding S.à r.l. | Ownership through | 10–14.99 % |
| Christian Henri Leroy | Ownership through | 5–9.99 % |
| 🇳🇱Londam Investments B.V. | Ownership through Direct | 5–9.99 % |
| Helle Annemarie Fisker | Ownership through | 2.5–6.66 % |
| Rune Fisker | Ownership through | 2.5–6.66 % |